Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05212883 · ClinicalTrials.gov registry record
You and Me COVID Free
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 2,778
- Enrollment target
NCT05212883: Completed study, sponsored by Duke University.
NCT05212883 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 2,778 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05212883 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 2,778 participants
- Enrollment target
Study Summary
Observational, study that distributes rapid at-home, self-administered, SARS-CoV-2 antigen testing kits to households within pre-selected communities.
Primary Outcome
Those that used a test from a kit were asked to provide the reason why they were doing a test. The possible answers are: "I wanted to be sure I/my child did not have COVID-19 before being around others", "I/my child had COVID-19 like symptoms", "I/my child was in close contact with someone who might have COVID-19", "I/my child was in close contact with someone who tested positive for COVID-19", "Someone in my household might have COVID-19", "Someone in my household tested positive for COVID-19",
Interventions
- BEHAVIORAL Behavioral questionaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,778 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2022-04-19 |
What the finished NCT05212883 record still lists
NCT05212883 is an observational study that tracks outcomes without assigning an intervention. Its 2,778 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Behavioral questionaires is the first listed.
NCT05212883 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05212883 about?
NCT05212883 is a clinical study titled "You and Me COVID Free". Observational, study that distributes rapid at-home, self-administered, SARS-CoV-2 antigen testing kits to households within pre-selected communities.
What is the current status of trial NCT05212883?
This trial is currently completed. The enrollment target is 2,778 participants. The study started on 2021-11-15. Estimated completion is 2022-04-19.
What interventions are being tested in trial NCT05212883?
The interventions under investigation include: Behavioral questionaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT05212883?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
- NCT06345339 · 2,800 participants · Phase 2
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI